Microscopic polyangiitis is a rare condition where inflammation of small blood vessels can damage vital organs throughout the body, most commonly affecting the kidneys, lungs, nerves, and skin.
Microscopic polyangiitis, often shortened to MPA, is a disease that causes inflammation inside the walls of tiny blood vessels. When these small vessels become inflamed, they can weaken, narrow, or even close off entirely. This inflammation disrupts the normal flow of blood, oxygen, and nutrients to different parts of the body, which can lead to damage in organs and tissues. The condition is called “microscopic” not because it’s small in impact, but because the affected blood vessels are so tiny that the inflammation can only be seen under a microscope during tissue examination.[1]
This disease belongs to a larger family of conditions known as vasculitis, which simply means inflammation of blood vessels. More specifically, MPA is part of a group called ANCA-associated vasculitides, named after unusual proteins called antineutrophil cytoplasmic antibodies that are often found in the blood of people with these conditions. These antibodies attack certain white blood cells and are thought to play a role in causing the blood vessel inflammation, although the exact reason why the immune system behaves this way remains unclear.[3]
MPA shares many features with another similar condition called granulomatosis with polyangiitis, formerly known as Wegener’s granulomatosis. The main difference is that MPA does not cause the formation of granulomas, which are small clusters of inflamed tissue. Despite their differences, both conditions affect small blood vessels and are treated in similar ways.[1]
How Common Is Microscopic Polyangiitis?
Microscopic polyangiitis is considered a very rare disease. Studies suggest that it affects approximately 13 to 19 people per million in the population, making it an uncommon diagnosis that many doctors may only encounter a few times in their careers.[1]
The condition does not discriminate based on gender, appearing to affect men and women equally. While MPA can develop in people of any age, including children, it most commonly appears in middle-aged individuals, particularly those in their 50s and 60s. In the United States, the typical patient is described as a middle-aged adult, though there are many exceptions to this pattern. People from all ethnic backgrounds can develop MPA, though certain genetic factors may make some populations slightly more susceptible.[2][4]
What Causes Microscopic Polyangiitis?
The exact cause of microscopic polyangiitis remains unknown, which can be frustrating for patients trying to understand why they developed the condition. What researchers do know is that MPA is not a form of cancer, it is not contagious, and it typically does not run in families. This means you cannot catch it from someone else, and having a family member with the condition does not necessarily increase your risk of developing it.[1]
Current research strongly suggests that the immune system plays a central role in causing MPA. The immune system’s job is to protect the body from harmful invaders like bacteria and viruses. In MPA, something goes wrong with this protective system, causing it to mistakenly attack the body’s own blood vessels. This is why MPA is considered an autoimmune disease – a condition where the immune system turns against the body it’s supposed to protect.[4]
Scientists have identified that certain genes may increase a person’s susceptibility to developing MPA. These genetic factors appear to be more closely linked to the type of antibodies present in the blood rather than the specific disease pattern. However, having these genes does not guarantee someone will develop the condition, suggesting that other factors must also be involved.[15]
Some researchers believe that infections caused by viruses might trigger the disease in people who are genetically predisposed. Additionally, reactions to certain medications have been known to start inflammation in blood vessels. In some cases, MPA occurs alongside other autoimmune diseases, such as rheumatoid arthritis, though the connection between these conditions is not fully understood.[4]
Who Is at Risk for Developing MPA?
Because the exact cause of microscopic polyangiitis is not known, identifying specific risk factors is challenging. However, certain patterns have emerged from studying people who develop the condition. Age appears to be one factor, as the disease most commonly appears in people during middle age and older. The typical age range for diagnosis is the 50s and 60s, though younger adults and children can also develop MPA.[4]
Certain genetic factors may increase susceptibility to the disease. Research has shown that specific genetic variations are associated with the development of ANCA-associated vasculitis, though these genetic markers alone do not predict who will develop the disease. Environmental factors likely interact with genetic predisposition to trigger the condition.[15]
People with other autoimmune conditions may have a slightly higher risk of developing MPA. The condition sometimes appears in individuals who already have rheumatoid arthritis or other autoimmune diseases, suggesting that a generally overactive immune system might create an environment where MPA can develop.[4]
What Are the Symptoms of Microscopic Polyangiitis?
The symptoms of microscopic polyangiitis can vary significantly from person to person because the disease can affect many different organ systems throughout the body. This variability often makes diagnosis challenging, as symptoms may develop gradually or appear suddenly, and they can fluctuate in intensity over time. The inflammation may come and go, causing symptoms to improve or worsen unpredictably.[4]
Many people with MPA experience general symptoms that affect their overall well-being. These are called constitutional symptoms and include feeling generally unwell, persistent fatigue, fever, loss of appetite, and unintended weight loss. These symptoms occur because MPA is a systemic disease, meaning it affects the whole body rather than just one specific organ. Weight loss, in particular, is very common, affecting more than 70 percent of people with MPA.[2]
The kidneys are the organs most commonly affected by MPA, with inflammation occurring in approximately 80 to 90 percent of cases. This kidney inflammation, called glomerulonephritis, causes blood and protein to leak into the urine. The concerning aspect of kidney involvement is that it often produces no symptoms until the damage becomes severe. Patients may not feel any different even as their kidney function deteriorates. When symptoms do appear, they might include swelling in the legs, dark-colored urine, fatigue, and shortness of breath. Without prompt diagnosis and treatment, kidney failure can develop rapidly.[2][6]
Skin problems develop in more than 60 percent of people with MPA. These skin manifestations typically appear as purplish or reddish bumps and spots, particularly on the lower legs, feet, and buttocks. These are called palpable purpura because you can feel them when you touch the skin. The lesions can range from small spots just a few millimeters across to larger areas where the spots merge together. Some people may also develop small blisters or ulcers on the skin.[2]
Nerve damage occurs in about 60 percent of patients with MPA. This typically affects the peripheral nerves – those outside the brain and spinal cord that control sensation and movement in the arms and legs. People may first notice unusual sensations like tingling or numbness, often starting in the hands or feet. This can progress to weakness, making it difficult to grip objects or walk normally. The nerve damage pattern in MPA tends to affect individual nerves rather than causing widespread nerve problems.[2]
When MPA affects the lungs, it can cause serious problems including bleeding in the lung tissue. This condition, called pulmonary capillaritis, occurs when the tiny blood vessels in the lungs become inflamed and start to leak blood. Symptoms include shortness of breath, coughing up blood, and difficulty breathing. The lungs may fill with fluid, and over time, scar tissue can develop, making breathing progressively more difficult. Lung bleeding can occur early in the disease and requires immediate medical attention.[6]
Joint and muscle pain are common complaints, with many people experiencing aches throughout their bodies. Fevers occur in approximately 55 percent of patients. The digestive system can also be affected, causing abdominal pain, nausea, vomiting, and diarrhea. Sometimes blood appears in the stool. Other organs, including the heart and eyes, are less commonly affected but can still experience problems related to the blood vessel inflammation.[2][6]
How Can Microscopic Polyangiitis Be Prevented?
Unfortunately, because the exact cause of microscopic polyangiitis is not fully understood, there are no known methods to prevent the disease from developing in the first place. Unlike conditions that can be prevented through lifestyle changes, vaccinations, or avoiding certain exposures, MPA appears to result from a complex interaction of genetic susceptibility and unknown environmental triggers.[1]
However, once diagnosed, early detection and prompt treatment are crucial for preventing serious organ damage. Regular monitoring and adherence to treatment plans can help prevent disease flares and reduce the risk of complications. People with MPA need to maintain close contact with their healthcare team and report any new or worsening symptoms immediately, as early intervention can prevent irreversible damage to organs like the kidneys and lungs.[3]
How Does Microscopic Polyangiitis Affect the Body?
Understanding what happens inside the body during microscopic polyangiitis helps explain why the symptoms occur and why treatment is so important. The fundamental problem in MPA is inflammation of small blood vessels, particularly the capillaries, venules, and arterioles – the tiniest vessels that deliver oxygen and nutrients to tissues throughout the body.[3]
When these small blood vessels become inflamed, several harmful things can happen. The vessel walls may become weakened and thin, making them prone to rupture and causing bleeding into surrounding tissues. Alternatively, inflammation can cause the vessels to narrow or close off completely, cutting off blood supply to the organs they serve. Without adequate blood flow, tissues are deprived of oxygen and nutrients, leading to organ damage and malfunction.[1]
In the kidneys, the inflammation affects the glomeruli, which are tiny filtering units responsible for cleaning the blood and producing urine. When inflamed, these filters become leaky, allowing red blood cells and proteins to pass through into the urine when they should stay in the bloodstream. Over time, the damaged glomeruli become scarred and stop working, reducing the kidney’s ability to filter waste products from the blood. This process is called necrotizing vasculitis because the inflammation is severe enough to cause tissue death, and it occurs without the formation of immune complexes, which distinguishes it from some other types of kidney disease.[3]
In the lungs, inflammation of the capillaries causes them to leak blood into the air sacs where oxygen exchange normally occurs. This bleeding, combined with fluid accumulation and eventual scarring, interferes with the lungs’ ability to transfer oxygen into the bloodstream. The scarring process, called fibrosis, can become permanent, leaving patients with reduced lung function even after the active inflammation is controlled.[6]
The presence of antineutrophil cytoplasmic antibodies in the blood is a key feature of MPA’s mechanism. These abnormal antibodies attack a type of white blood cell called neutrophils, which are normally part of the body’s defense system. The interaction between these antibodies and neutrophils triggers a cascade of inflammatory reactions that damage blood vessel walls. Most people with MPA have a specific type of these antibodies called MPO-ANCA, which target an enzyme called myeloperoxidase, though not everyone with the disease tests positive for these antibodies.[3][15]
The systemic nature of MPA means that the inflammatory process is not limited to one area of the body. The same destructive process affecting kidney capillaries can simultaneously damage vessels in the skin, lungs, nerves, and other organs. This explains why people with MPA often have multiple organ systems involved and why comprehensive treatment targeting the underlying immune dysfunction is necessary rather than treating individual organs separately.[1]
